Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Aust N Z J Psychiatry. 2023 Dec 21:48674231209840. doi: 10.1177/00048674231209840. Online ahead of print.
ABSTRACT
The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.
PMID:38130026 | DOI:10.1177/00048674231209840
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Antipsychotic medications and severe sepsis in schizophrenia: A nested case-control study HIV Viral Suppression Among Psychiatric Inpatients with Schizophrenia in San Francisco: A Retrospective Cohort Study GLP-1 receptor agonists and weight loss in schizophrenia - past, present, and future An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents A lifetime of mental health treatments for people with schizophrenia: update and narrative review Continuation or maintenance ECT for schizophrenia: A narrative review of case report data Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study 'A certain magic' - autistic adults' experiences of interacting with other autistic people and its relation to Quality of Life: A systematic review and thematic meta-synthesis 'A certain magic' - autistic adults' experiences of interacting with other autistic people and its relation to Quality of Life: A systematic review and thematic meta-synthesis Research Letter: Perceived rather than actual reduction in standard of living is associated with psychological distress: A cross-sectional survey of working Australians Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor D-serine and D-amino acid oxidase levels in patients with schizophrenia spectrum disorders in the first episode and 6-month follow-up Luxenburger's 1939 Essay on "Schizophrenia and its Hereditary Circle" Palliative psychiatry for a patient with treatment-refractory schizophrenia and severe chronic malignant catatonia: case report A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia Longitudinal association of social isolation and loneliness with physical function among in-patients living with schizophrenia Mirtazapine Monotherapy for Antipsychotics-refractory Psychosis in a Patient with Very-late-onset Schizophrenia-like Psychosis: A Case Report Modulation of mGlu5 reduces rewarding associative properties of nicotine via changes in mesolimbic plasticity: Relevance to comorbid cigarette smoking in psychosis Average lifespan variation among people with mental disorders in Denmark: a nationwide, register-based cohort study New drug treatments for schizophrenia: a review of approaches to target circuit dysfunction The identification of novel schizophrenia-related metabolites using untargeted lipidomics Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series First 150 years of catatonia: Looking back at its complicated history and forward to the road ahead Prevalence and risk factors for chronic kidney disease among older adult patients with schizophrenia in Taiwan Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study A Case of Risperidone-Induced Urinary Incontinence Maternity in women with schizophrenia and schizoaffective disorder Suicide attempts in schizophrenia - A large retrospective cohort study from a tertiary care psychiatry centre in India Striatum and globus pallidus structural abnormalities in schizophrenia: A retrospective study of the different stages of the disease Parental mental disorders in patients with comorbid schizophrenia and obsessive-compulsive disorder: a nationwide family-link study Multimorbidity and the Etiology of Schizophrenia Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study Brain Abnormalities in Schizophrenia: A Comparative Imagistic Study Commando care for individuals living with severe mental illness: Equally Well goes beyond metabolic health alone Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine Atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model) Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders Outcomes following hip fracture surgery in adults with schizophrenia in Ontario, Canada: A 10-year population-based retrospective cohort study Relationships between erythrocyte membrane mono- and poly- unsaturated fatty acid composition and clinical/cognitive indices in antipsychotic-free schizophrenia patients "People don't have the answers": A qualitative exploration of the experiences of young people with Long COVID Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland Research progress in mitochondrial quality control in schizophrenia Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland EXPRESS: Emotional anticipation for dynamic emotional faces is not modulated by schizotypal traits: A Representational Momentum study Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature 18q Deletion Syndrome-Associated Schizophrenia: A Case Report Examining the impact of substance use on hospital length of stay in schizophrenia spectrum disorder: a retrospective analysis 18q Deletion Syndrome-Associated Schizophrenia: A Case Report Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia Advancing the Measurement of Social Functioning in Schizophrenia: Applications of Egocentric Social Network Analysis Protein Profiles and Novel Molecular Biomarkers of Schizophrenia Based on 4D-DIA Proteomics Delusions and Delinquencies: A Comparison of Violent and Non-Violent Offenders With Schizophrenia Spectrum Disorders Association between psychiatric admissions in patients with schizophrenia and IL-6 plasma levels polygenic score
Evidence Blueprint
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia Making meaning of multimorbidity and severe mental illness: A viewpoint Antipsychotic medications and severe sepsis in schizophrenia: A nested case-control study Clozapine-induced eosinophilia: A case report Letter to the Editor: Letter to the Editor regarding 'A challenge to the dopamine orthodoxy in schizophrenia?' Letter to the Editor: Letter to the Editor regarding 'A challenge to the dopamine orthodoxy in schizophrenia' HIV Viral Suppression Among Psychiatric Inpatients with Schizophrenia in San Francisco: A Retrospective Cohort Study GLP-1 receptor agonists and weight loss in schizophrenia - past, present, and future Physical health monitoring for people with schizophrenia What are the autism research priorities of autistic adults in Scotland? Schizophrenia: from neurochemistry to circuits, symptoms and treatments P300 in Schizophrenia: Then and Now An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents A lifetime of mental health treatments for people with schizophrenia: update and narrative review The development of type 2 diabetes management in people with severe mental illness in the Capital Region of Denmark from 2001 to 2015 Continuation or maintenance ECT for schizophrenia: A narrative review of case report data Prevalence and Correlates Of Sexual Dysfunction Among Patients With Schizophrenia Spectrum Disorder on Antipsyhotic Medications in Maiduguri, Northeastern Nigeria Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice The contribution of first-episode illness characteristics and cumulative antipsychotic usage to progressive structural brain changes over a long-term follow-up in schizophrenia Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: A territory-wide nested case-control study spanning two decades Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder Association of hypertension, type 2 diabetes mellitus and dyslipidemia with the duration of inpatient treatments and recurrence of schizophrenia 'A certain magic' - autistic adults' experiences of interacting with other autistic people and its relation to Quality of Life: A systematic review and thematic meta-synthesis 'A certain magic' - autistic adults' experiences of interacting with other autistic people and its relation to Quality of Life: A systematic review and thematic meta-synthesis Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019 Research Letter: Perceived rather than actual reduction in standard of living is associated with psychological distress: A cross-sectional survey of working Australians Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial Psychotic Experiences and Daily Functioning in Borderline Personality Disorder and Schizophrenia Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor D-serine and D-amino acid oxidase levels in patients with schizophrenia spectrum disorders in the first episode and 6-month follow-up Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community Supports that help me to live well in the community: experiences of people living with schizophrenia Schizophrenia in Autistic People with Intellectual Disabilities. Treatment and Interventions Schizophrenia and the COVID-19 pandemic: A narrative review from the biomedical perspective Empathy in the Care of Individuals With Schizophrenia: A Vital Element of Treatment Luxenburger's 1939 Essay on "Schizophrenia and its Hereditary Circle" The association of lower urinary tract symptoms with schizophrenia and its treatments: A narrative review The effect of vortioxetine on anhedonia in patients with schizophrenia Palliative psychiatry for a patient with treatment-refractory schizophrenia and severe chronic malignant catatonia: case report Estrogen and psychosis - a review and future directions An international research agenda for clozapine-resistant schizophrenia Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia Cross-sectional study on the dissociation of decision-making capacity for antipsychotic treatment and COVID-19 vaccination in individuals with schizophrenia Career progression for autistic people: A scoping review Orphan GPR52 as an emerging neurotherapeutic target The Associative Thalamus: A Switchboard for Cortical Operations and a Promising Target for Schizophrenia The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia Excess mortality and its causes among older adults with schizophrenia versus those with bipolar disorder and major depressive disorder: a 5-year prospective multicenter study Hypersexuality during treatment with cariprazine in a patient with schizophrenia? A case report Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study Expert Comment: Three factors that help beat the odds in Young Lives Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings? Antipsychotic medication non-adherence and factors associated among patients with schizophrenia in eastern Ethiopia